Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model

References

1. Allen G. P., Bryans J. T. 1986; Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. Progress in Veterinary Microbiology and Immunology 2:78–144
   [Google Scholar]
2. Allen G. P., Coogle L. D. 1988; Characterization of an equine herpesvirus type-1 gene encoding glycoprotein 13 (gp13) with homology to herpes simplex virus glycoprotein C. Journal of Virology 62:2850–28
   [Google Scholar]
3. Allen G. P., Yeargen M. R. 1987; Use of lambda gt 11 and monoclonal antibodies to map the genes for the six major glycoproteins of EHV-1. Journal of Virology 61:2454–2461
   [Google Scholar]
4. Allen G. P., Yeargen M. R., Coogle L. D. 1988; Equid herpesvirus-1 glycoprotein 13 (gp13): epitope analysis, gene structure and expression in E. coli . In Equine Infectious Diseases. V. Proceedings of the Fifth International Conference pp 103–110 Edited by Powell D. G. Kentucky: University Press of Kentucky;
   [Google Scholar]
5. Anderson K., Goodpasture E. W. 1942; Infection of newborn Syrian hamsters with the virus of mare abortion. American Journal of Pathology 18:555–559
   [Google Scholar]
6. Anonymous 1989; Warning over equine herpesvirus outbreak. Veterinary Record 124:416
   [Google Scholar]
7. Blacklaws B. A., Nash A. A., Darby G. 1987; Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. Journal of General Virology 68:1103–1114
   [Google Scholar]
8. Bracken E. C., Randall C. C. 1957; Studies on hepatitis in hamsters infected with equine abortion virus. American Journal of Pathology 33:1009–1022
   [Google Scholar]
9. Bridges C. G., Ledger N., Edington N. 1988; The characterization of equine herpesvirus-1 infected cell polypeptides recognized by equine lymphocytes. Immunology 63:193–198
   [Google Scholar]
10. Browning G. F., Bulach D. M., Ficorilli N., Roy E. A., Thorp B. H., Studdert M. J. 1989; Latency of equine herpesvirus 4 (equine rhinopneumonitis virus). Veterinary Record 123:518–519
    [Google Scholar]
11. Burrows R. 1968; Rhinopneumonitis virus neutralizing antibody levels of British thoroughbred mares. In Proceedings of the First International Conference on Equine Infectious Diseases pp 306–321 Edited by Bryans J. T., Gerber H. Lexington: Graystone Foundation;
    [Google Scholar]
12. Burrows R., Goodridge D. 1973; In vivo and in vitro studies of equine rhinopneumonitis strains. In Proceedings of the Third International Conference on Equine Infectious Diseases pp 306–321 Edited by Bryans J., Gerber H. Basel: S. Karger;
    [Google Scholar]
13. Burrows R., Goodridge D. 1978; Equid herpesvirus 1 (EHV-1): some observations on the epizootiology of infection and on the innocuity testing of live virus vaccines. In Proceedings of the 24th Annual Convention of the American Association of Equine Practitioners pp 17–29 Edited by Milne F. J. St. Louis, Missouri: American Association of Equine Practitioners;
    [Google Scholar]
14. Burrows R., Goodridge D., Denyer M. S. 1984; Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype-1 virus. Veterinary Record 114:369–374
    [Google Scholar]
15. Chowdhury S. I., Kubin G., Ludwig H. 1986; Equine herpesvirus type-I (EHV-1) induced abortions and paralysis in a Lipizzaner stud: a contribution to the classification of equine herpesviruses. Archives of Virology 90:273–288
    [Google Scholar]
16. Crandell R. A., Angulo A. B. 1985; Equine herpesvirus-1 antibodies in stillborn foals and weak neonates. Veterinary Medicine 80:73–76
    [Google Scholar]
17. Cullinane A. A., Rixon F. J., Davison A. J. 1988; Characterization of the genome of equine herpesvirus 1 subtype 2. Journal of General Virology 69:1575–1590
    [Google Scholar]
18. Doll E. R., Wallace E. 1954; Cultivation of equine abortion and equine influenza viruses on the chorioallantoic membrane of chick embryos. Cornell Veterinarian 44:453–461
    [Google Scholar]
19. Edington N., Bridges C. G., Huckle A. 1985; Experimental reactivation of equid herpesvirus 1 (EHV-1) following the administration of corticosteroids. Equine Veterinary Journal 17:369–372
    [Google Scholar]
20. Friedman H. M., Cohen G. H., Eisenberg R. J., Seidel C. A., Cines D. B. 1984; Glycoprotein C of herpes simplex virus acts as a receptor for the C3b complement component on infected cells. Nature, London 309:633–635
    [Google Scholar]
21. Guo P., Goebel S., Davis S., Perkus M. E., Languet B., Desmettre P., Allen G. P., Paoletti E. 1989; Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals. Journal of Virology 63:4189–4198
    [Google Scholar]
22. Heber-Katz E., Valentine S., Dietzschold B., Burns-Pur-zycki C. 1988; Overlapping T-cell antigenic sites on a synthetic peptide fragment from herpes simplex virus glycoprotein D, the degenerate MHC restriction elicited, and functional evidence for antigen-la interaction. Journal of Experimental Medicine 167:275–284
    [Google Scholar]
23. Hopp T. P., Woods K. R. 1981; Prediction of protein antigenic determinants from amino acid sequences. Proceedings of the National Academy of Sciences, U,. S,. A 78:3824–3828
    [Google Scholar]
24. Jennings S. R., Lippe P. A., Pauza K. J., Spear P. J., Pereira L., Tevethia S. S. 1987; Kinetics of expression of herpes simplex virus type-1-specific glycoprotein species on the surfaces of infected murine, simian and human cells: flow cytometric analysis. Journal of Virology 61:104–112
    [Google Scholar]
25. Kumel G., Kaerner M. C., Levine M., Schroder C. H., Glorioso J. C. 1985; Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody resistant mutants altered in pathogenicity. Journal of Virology 56:930–937
    [Google Scholar]
26. Lopez C., O’Reilly R. J. 1977; Cell mediated immune responses in recurrent herpesvirus infections. 1. Lymphocyte proliferation assay. Journal of Immunology 118:895–902
    [Google Scholar]
27. McNearney T. A., Odell C., Holers V. M., Spear P. G., Atkinson J. P. 1987; Herpes simplex glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement mediated neutralization of viral infectivity. Journal of Experimental Medicine 166:1525–1535
    [Google Scholar]
28. Martin S., Cantin E., Rouse B. T. 1989; Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins. Journal of General Virology 70:1359–1370
    [Google Scholar]
29. Meredith D. M., Stocks J.-M., Whittaker G. R., Halliburton I. W., Snowden B. W., Killington R. A. 1989; Identification of the gB homologues of equine herpesvirus types 1 and 4 as disulphide-linked heterodimers and their characterization using monoclonal antibodies. Journal of General Virology 70:1161–1172
    [Google Scholar]
30. Merrifield R. B., Vizioli L. D., Boman H. G. 1982; Synthesis of the antibacterial cecropin A (1-33). Biochemistry 21:5020–5030
    [Google Scholar]
31. Mumford J. A., Bates J. 1984; Trials of an inactivated equid herpesvirus I vaccine: challenge with a subtype-2 virus. Veterinary Record 114:375–381
    [Google Scholar]
32. Nicolson L., Onions D. E. 1990; The nucleotide sequence of the equine herpesvirus 4 gC gene homologue. Virology 179:378–387
    [Google Scholar]
33. Papp-Vid G., Derbyshire J. B. 1978; The protective antigens of equine herpesvirus type-1. Canadian Journal of Comparative Medicine 42:219–226
    [Google Scholar]
34. Rector J. T., Lausch R. N., Oakes J. E. 1982; Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type-1 infection. Infection and Immunity 38:168–174
    [Google Scholar]
35. Riggio M. P., Cullinane A. A., Onions D. E. 1989; Identification and nucleotide sequence of the glycoprotein gB gene of equine herpesvirus 4. Journal of Virology 63:1123–1133
    [Google Scholar]
36. Sabine M., Robertson G. R., Whalley J. M. 1981; Differentiation of subtypes of equine herpesvirus-1 by restriction endonuclease analysis. Australian Veterinary Journal 57:148–149
    [Google Scholar]
37. Shimizu M., Satou K., Nishioka N. 1989; Monoclonal antibodies with neutralizing activity to equine herpesvirus 1. Archives of Virology 104:169–174
    [Google Scholar]
38. Sinclair R., Cook R. F., Mumford J. A. 1989; The characterization of neutralizing and non-neutralizing monoclonal antibodies against equid herpesvirus type 1. Journal of General Virology 70:455–459
    [Google Scholar]
39. Spiegelberg H. L. 1974; Biological activities of immunoglobulins of different classes and subclasses. Advances in Immunology 19:259294
    [Google Scholar]
40. Stewart J. M., Young J. D. 1984 Solid Phase Peptide Synthesis, 2nd. edn Rockford, Illinois: Pierce Chemical Company;
    [Google Scholar]
41. Stokes A., Wardley R. C. 1988; ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse. Research in Veterinary Science 44:295–302
    [Google Scholar]
42. Stokes A., Allen G. P., Pullen L. A., Murray P. K. 1989; A hamster model of equine herpesvirus type 1 (EHV-1) infection: passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. Journal of General Virology 70:1173–1183
    [Google Scholar]
43. Studdert M. J., Simpson T., Roizman B. 1981; Differentiation of respiratory and abortogenic isolates of EHV-1 by restriction endonucleases. Science 214:562–564
    [Google Scholar]
44. Sullivan V., Smith G. L. 1987; Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody. Journal of General Virology 68:2587–2598
    [Google Scholar]
45. Weijer W. J., Drijfhout J. W., Geerligs H. J., Bloemhoff W., Feijlbrief M., Bos C. A., Hoogerhout P., Kerling C. E. T., Popken-Boer T., Slopsema K., Wilterdink J. B., Welling G. W., Welling-Wester S. 1988; Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their ability to neutralize viral infectivity in vitro . Journal of Virology 62:501–510
    [Google Scholar]
46. Weir J. P., Bennett M., Allen E. M., Elkins K. L., Martin S., Rouse B. T. 1989; Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. Journal of General Virology 70:2587–2594
    [Google Scholar]
47. Whalley J. M., Robertson G. R., Scott N. A., Hudson G. C., Bell C. W., Woodworth L. M. 1989; Identification and nucleotide sequence of a gene in equine herpesvirus 1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB. Journal of General Virology 70:383–394
    [Google Scholar]
48. Wilks C. R., Coggins L. 1977; Protective immunity in equine herpesvirus type-1 infection of hamsters. Cornell Veterinarian 67:385–403
    [Google Scholar]
49. Wu C. T. B., Levine M., Homa F., Highlander S. L., Glorioso J. C. 1980; Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants. Journal of Virology 64:856–863
    [Google Scholar]
50. Yeargen M. R., Allen G. P., Bryans J. T. 1985; Rapid subtyping of EHV-1 with monoclonal antibodies. Journal of Clinical Microbiology 21:694–697
    [Google Scholar]